[{"NetIncomeLoss_1_Q3_USD":-108586000.0,"DepreciationAndAmortization_3_Q3_USD":10937000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":77546000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":26982000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":178203000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":179090000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":317000.0,"InterestPaidNet_3_Q3_USD":9742000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-1080000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":403473000.0,"AssetsCurrent_0_Q3_USD":1043856000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-1150000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":791445000.0,"ContractWithCustomerLiability_0_Q3_USD":3001000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":15154000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":5570000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":17499000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":16575000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1455000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":423000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-2144000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":11188000.0,"Assets_0_Q3_USD":1508666000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-75000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-1795000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":128985000.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":9340000.0,"Liabilities_0_Q3_USD":337685000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":100531000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":1158722000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":9000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":16453000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":2910000.0,"AccountsReceivableNetCurrent_0_Q3_USD":42925000.0,"RepaymentsOfSeniorDebt_3_Q3_USD":250000000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":365000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":21000.0,"CommonStockValue_0_Q3_USD":18000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":197715000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":20478000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-229349000.0,"CostsAndExpenses_3_Q3_USD":443843000.0,"CostsAndExpenses_1_Q3_USD":133083000.0,"OtherAssetsCurrent_0_Q3_USD":21550000.0,"IncreaseDecreaseInInventories_3_Q3_USD":227000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-327312000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-110381000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-3337000.0,"OtherAssetsNoncurrent_0_Q3_USD":1420000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":55843000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":139022000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":3363998000.0,"Cash_0_Q3_USD":6368000.0,"SeniorNotesCurrent_0_Q3_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"InterestReceivableCurrent_0_Q3_USD":5400000.0,"Goodwill_0_Q3_USD":76501000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-326872000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-108565000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":23667000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-498000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":349000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-214653000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1387000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":41700000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q3_USD":0.0,"LiabilitiesCurrent_0_Q3_USD":126500000.0,"AccountsPayableCurrent_0_Q3_USD":15484000.0,"NonoperatingIncomeExpense_3_Q3_USD":-12482000.0,"NonoperatingIncomeExpense_1_Q3_USD":-5515000.0,"InterestExpense_3_Q3_USD":6851000.0,"InterestExpense_1_Q3_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":55843000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":20651000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_3_Q3_shares":2889000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_1_Q3_shares":584000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":9630000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":5588000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":60189000.0,"NetIncomeLoss_3_Q3_USD":-327237000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":5070000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q3_USD":22700000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":109400000.0,"CommonStockSharesOutstanding_0_Q3_shares":179394000.0,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":129453000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":30033000.0,"OperatingIncomeLoss_3_Q3_USD":-314390000.0,"OperatingIncomeLoss_1_Q3_USD":-103050000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":900163000.0,"InventoryNet_0_Q3_USD":12892000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":507000.0,"PreferredStockValue_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1508666000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":29504000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":305954000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":72274000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":15348000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":2133000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.84,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.61,"ProfitLoss_3_Q3_USD":-327237000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3291000.0,"StockholdersEquity_0_Q3_USD":1170981000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":2494000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":5504000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-2191955000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-40520000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":6123000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":23667000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-5070000.0,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]